Dara Grantham Wright
Net Worth
Last updated:
What is Dara Grantham Wright net worth?
The estimated net worth of Ms. Dara Grantham Wright is at least $14,687,916 as of 16 Dec 2023. She owns shares worth $428,924 as insider, has earned $358,992 from insider trading and has received compensation worth at least $13,900,000 in Bio-Rad Laboratories, Inc. and Bio-Rad Laboratories, Inc..
What is the salary of Dara Grantham Wright?
Ms. Dara Grantham Wright salary is $1,390,000 per year as Executive Vice President & Pres of Clinical Diagnostics Group in Bio-Rad Laboratories, Inc.. She also receives $1,390,000 as Executive Vice President & Pres of Clinical Diagnostics Group in Bio-Rad Laboratories, Inc..
How old is Dara Grantham Wright?
Ms. Dara Grantham Wright is 49 years old, born in 1976.
What stocks does Dara Grantham Wright currently own?
As insider, Ms. Dara Grantham Wright owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Executive Vice President & Pres of Clinical Diagnostics Group | 1,499 | $286.14 | $428,924 |
What does Bio-Rad Laboratories, Inc. do?
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Dara Grantham Wright insider trading
Bio-Rad Laboratories, Inc.
Ms. Dara Grantham Wright has made only one insider trade between 2020-2023, according to the Form 4 filled with the SEC.
As of 16 Dec 2023 she still owns at least 1,499 units of BIO stock.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories key executives
Bio-Rad Laboratories, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew J. Last (65) Executive Vice President & Chief Operating Officer
- Mr. Ilan Daskal (59) Executive Vice President & Chief Financial Officer
- Mr. Norman D. Schwartz (75) Chairman, Chief Executive Officer & Pres
- Ms. Dara Grantham Wright (49) Executive Vice President & Pres of Clinical Diagnostics Group